Description

This 90-minute webinar will explore the processes, considerations, and other factors behind the incubation and launch of new companies by some of today’s leading venture capital firms. 

We’ll address the following key questions and topics: 

• What are common sources of ideas for new companies and how do VC business models facilitate and measure the progress and de-risking of translational science? 
• How do venture firms approach financing a new entity and how do they balance capital at risk and value capture with syndication and/or non-dilutive funding from partnerships? 
• What are venture firms’ views on founder equity for inventors, for initial key team members, and for their own firms in their capacity as new company founders? 
• What are key steps to creating an ideal initial management team?

REGISTER HERE

Speakers

Lewis Geffen 
Member / Co-chair, Life Sciences and Venture Capital & Emerging Companies Practices, Mintz

Nessan Bermingham, PhD 
Serial entrepreneur and investor; currently 
President & CEO, Triplet Therapeutics,
Executive Chairman, Korro Bio

Nathaniel Brooks Horwitz 
Principal, Venture Team, RA Capital Management; board member of multiple companies

Deborah Palestrant, PhD 
Partner, Head of 4:59, 5AM Ventures